{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:28:17Z","timestamp":1784302097878,"version":"3.55.0"},"reference-count":57,"publisher":"Portland Press Ltd.","issue":"21","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:p>We previously developed cardiac ventricle-specific choline acetyltransferase (ChAT) gene-overexpressing transgenic mice (ChAT tgm), i.e. an in\u00a0vivo model of the cardiac non-neuronal acetylcholine (NNA) system or non-neuronal cardiac cholinergic system (NNCCS). By using this murine model, we determined that this system was responsible for characteristics of resistance to ischaemia, or hypoxia, via the modulation of cellular energy metabolism and angiogenesis. In line with our previous study, neuronal ChAT-immunoreactivity in the ChAT tgm brains was not altered from that in the wild-type (WT) mice brains; in contrast, the ChAT tgm hearts were the organs with the highest expression of the ChAT transgene. ChAT tgm showed specific traits in a central nervous system (CNS) phenotype, including decreased response to restraint stress, less depressive-like and anxiety-like behaviours and anti-convulsive effects, all of which may benefit the heart. These phenotypes, induced by the activation of cardiac NNCCS, were dependent on the vagus nerve, because vagus nerve stimulation (VS) in WT mice also evoked phenotypes similar to those of ChAT tgm, which display higher vagus nerve discharge frequency; in contrast, lateral vagotomy attenuated these traits in ChAT tgm to levels observed in WT mice. Furthermore, ChAT tgm induced several biomarkers of VS responsible for anti-convulsive and anti-depressive-like effects. These results suggest that the augmentation of the NNCCS transduces an effective and beneficial signal to the afferent pathway, which mimics VS. Therefore, the present study supports our hypothesis that activation of the NNCCS modifies CNS to a more stress-resistant state through vagus nerve activity.<\/jats:p>","DOI":"10.1042\/cs20160277","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T00:47:50Z","timestamp":1471308470000},"page":"1913-1928","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Non-neuronal cardiac cholinergic system influences CNS via the vagus nerve to acquire a stress-refractory propensity"],"prefix":"10.1042","volume":"130","author":[{"given":"Shino","family":"Oikawa","sequence":"first","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tsuda","sequence":"additional","affiliation":[{"name":"Institute for Laboratory Animal Research, Kochi Medical School, Nankoku, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayuki","family":"Ohata","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Mano","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Dentistry, Meikai University, Sakaido, Saitama 350-0283, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuei","family":"Sugama","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nemoto","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kurabayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyo","family":"Muramoto","sequence":"additional","affiliation":[{"name":"Department of Physiology, School of Dentistry, Meikai University, Sakaido, Saitama 350-0283, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kaneda","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Kakinuma","sequence":"additional","affiliation":[{"name":"Department of Physiology, Nippon Medical School Graduate School of Medicine, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"2021113010490533900_B1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0163-7258(97)00085-5","article-title":"Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans","volume":"77","author":"Wessler","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"2021113010490533900_B2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1523-1747.ep12358588","article-title":"Human keratinocytes synthesize, secrete, and degrade acetylcholine","volume":"101","author":"Grando","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"2021113010490533900_B3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1254\/jphs.FM0070087","article-title":"Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors","volume":"106","author":"Grando","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"2021113010490533900_B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2012.06516.x","article-title":"Reconciling neuronally and nonneuronally derived acetylcholine in the regulation of immune function","volume":"1261","author":"Kawashima","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021113010490533900_B5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2013.12.003","article-title":"SLURP-1, an endogenous \u03b17 nicotinic acetylcholine receptor allosteric ligand, is expressed in CD205(+) dendritic cells in human tonsils and potentiates lymphocytic cholinergic activity","volume":"267","author":"Fujii","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"2021113010490533900_B6","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1111\/j.1742-4658.2009.07208.x","article-title":"Cholinoceptive and cholinergic properties of cardiomyocytes involving an amplification mechanism for vagal efferent effects in sparsely innervated ventricular myocardium","volume":"276","author":"Kakinuma","year":"2009","journal-title":"FEBS J."},{"key":"2021113010490533900_B7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.autneu.2010.04.011","article-title":"Acetylcholine as an age-dependent non-neuronal source in the heart","volume":"156","author":"Rana","year":"2010","journal-title":"Auton. Neurosci."},{"key":"2021113010490533900_B8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.yjmcc.2012.05.003","article-title":"Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals","volume":"53","author":"Rocha-Resende","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113010490533900_B9","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.1096\/fj.13-238279","article-title":"Cardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heart","volume":"27","author":"Roy","year":"2013","journal-title":"FASEB J."},{"key":"2021113010490533900_B10","doi-asserted-by":"publisher","first-page":"e50761","DOI":"10.1371\/journal.pone.0050761","article-title":"A non-neuronal cardiac cholinergic system plays a protective role in myocardium salvage during ischemic insults","volume":"7","author":"Kakinuma","year":"2012","journal-title":"PLoS One"},{"key":"2021113010490533900_B11","doi-asserted-by":"publisher","first-page":"e004887","DOI":"10.1161\/JAHA.112.004887","article-title":"Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1\u03b1-related defense mechanisms","volume":"2","author":"Kakinuma","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"2021113010490533900_B12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1159\/000363042","article-title":"A non-neuronal cholinergic system regulates cellular ATP levels to maintain cell viability","volume":"34","author":"Oikawa","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"2021113010490533900_B13","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.febslet.2005.02.065","article-title":"Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha","volume":"579","author":"Kakinuma","year":"2005","journal-title":"FEBS Lett."},{"key":"2021113010490533900_B14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"2021113010490533900_B15","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0091-3057(94)90239-9","article-title":"Effect of changes in swimming area on results of \u201cbehavioral despair test\u201d","volume":"49","author":"Sunal","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"2021113010490533900_B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2015.08.015","article-title":"Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson's disease","volume":"51","author":"Sugama","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"2021113010490533900_B17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.expneurol.2009.05.035","article-title":"Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL\/6 mice","volume":"219","author":"M\u00fcller","year":"2009","journal-title":"Exp. Neurol."},{"key":"2021113010490533900_B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2013.05.040","article-title":"The role of \u03b12-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice","volume":"714","author":"Shafaroodi","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"2021113010490533900_B19","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/j.1460-9568.2006.04662.x","article-title":"Transcranial fluorescence imaging of auditory cortical plasticity regulated by acoustic environments in mice","volume":"23","author":"Takahashi","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"2021113010490533900_B20","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1523\/JNEUROSCI.2597-11.2011","article-title":"Preictal and ictal neurovascular and metabolic coupling surrounding a seizure focus","volume":"31","author":"Zhao","year":"2011","journal-title":"J. Neurosci."},{"key":"2021113010490533900_B21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.autneu.2013.02.014","article-title":"In\u00a0vivo monitoring of acetylcholine release from cardiac vagal nerve endings in anesthetized mice","volume":"176","author":"Zhan","year":"2013","journal-title":"Auton. Neurosci."},{"key":"2021113010490533900_B22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.biopsych.2012.10.021","article-title":"Rapid remission of conditioned fear expression with extinction training paired with vagus nerve stimulation","volume":"73","author":"Pe\u00f1a","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"2021113010490533900_B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yebeh.2015.09.031","article-title":"Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy","volume":"53","author":"Wasade","year":"2015","journal-title":"Epilepsy Behav."},{"key":"2021113010490533900_B24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neubiorev.2015.06.019","article-title":"The antidepressant mechanism of action of vagus nerve stimulation: evidence from preclinical studies","volume":"56","author":"Grimonprez","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"2021113010490533900_B25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.yjmcc.2009.11.010","article-title":"Donepezil, an acetylcholinesterase inhibitor against Alzheimer's dementia, promotes angiogenesis in an ischemic hindlimb model","volume":"48","author":"Kakinuma","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2021113010490533900_B26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.intimp.2015.06.004","article-title":"Remote ischemic preconditioning with a specialized protocol activates the non-neuronal cardiac cholinergic system and increases ATP content in the heart","volume":"29","author":"Oikawa","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"2021113010490533900_B27","first-page":"391","article-title":"A critical review of the use of carvedilol in ischemic heart disease","volume":"12","author":"Chen-Scarabelli","year":"2012","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"2021113010490533900_B28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010490533900_B29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.CIR.0000105721.71640.DA","article-title":"Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats","volume":"109","author":"Li","year":"2004","journal-title":"Circulation"},{"key":"2021113010490533900_B30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/eurjhf\/hfp071","article-title":"Long term vagal stimulation in patients with advanced heart failure: first experience in man","volume":"11","author":"Schwartz","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"2021113010490533900_B31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehq391","article-title":"Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure","volume":"32","author":"De Ferrari","year":"2011","journal-title":"Eur. Heart J."},{"key":"2021113010490533900_B32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10741-010-9216-0","article-title":"Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions","volume":"16","author":"De Ferrari","year":"2011","journal-title":"Heart Fail. Rev."},{"key":"2021113010490533900_B33","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1111\/bph.13010","article-title":"Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases","volume":"172","author":"He","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"2021113010490533900_B34","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.104.525493","article-title":"Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein","volume":"112","author":"Ando","year":"2005","journal-title":"Circulation"},{"key":"2021113010490533900_B35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jtcvs.2008.08.020","article-title":"Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect","volume":"137","author":"Katare","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"2021113010490533900_B36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cardiores.2004.01.012","article-title":"Localization of cholinergic innervation in guinea pig heart by immunohistochemistry for high-affinity choline transporters","volume":"62","author":"Hoover","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"2021113010490533900_B37","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.4103\/2152-7806.91610","article-title":"Vagus nerve stimulation for epilepsy: a review of the peripheral mechanisms","volume":"3","author":"Krahl","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"2021113010490533900_B38","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1111\/j.1528-1157.2000.tb00113.x","article-title":"Slow hyperpolarization in cortical neurons: a possible mechanism behind vagus nerve simulation therapy for refractory epilepsy?","volume":"41","author":"Zagon","year":"2000","journal-title":"Epilepsia"},{"key":"2021113010490533900_B39","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.4103\/2152-7806.103014","article-title":"Central mechanisms of cranial nerve stimulation for epilepsy","volume":"3","author":"Fanselow","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"2021113010490533900_B40","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.4103\/2152-7806.103015","article-title":"Vagus nerve stimulation for epilepsy: A review of central mechanisms","volume":"3","author":"Krahl","year":"2012","journal-title":"Surg. Neurol. Int."},{"key":"2021113010490533900_B41","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1212\/WNL.0b013e3182a393d1","article-title":"Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"81","author":"Morris","year":"2013","journal-title":"Neurology"},{"key":"2021113010490533900_B42","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jad.2013.05.080","article-title":"Vagus nerve stimulation for chronic major depressive disorder: 12-month outcomes in highly treatment-refractory patients","volume":"150","author":"Christmas","year":"2013","journal-title":"J. Affect. Disord."},{"key":"2021113010490533900_B43","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/pcn.12166","article-title":"Vagus nerve stimulation therapy in treatment-resistant depression: a series report","volume":"68","author":"Tisi","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"2021113010490533900_B44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12888-015-0435-8","article-title":"Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study","volume":"15","author":"Albert","year":"2015","journal-title":"BMC Psychiatry"},{"key":"2021113010490533900_B45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1471-4159.2011.07214.x","article-title":"Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model","volume":"117","author":"Raedt","year":"2011","journal-title":"J. Neurochem."},{"key":"2021113010490533900_B46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1124\/jpet.111.188953","article-title":"Comparison of \u0394FosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants","volume":"341","author":"Furmaga","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021113010490533900_B47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.intimp.2015.05.029","article-title":"Future perspectives of a cardiac non-neuronal acetylcholine system targeting cardiovascular diseases as an adjunctive tool for metabolic intervention","volume":"29","author":"Kakinuma","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"2021113010490533900_B48","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.RES.0000106133.92737.27","article-title":"Signaling mechanisms that mediate nitric oxide production induced by acetylcholine exposure and withdrawal in cat atrial myocytes","volume":"93","author":"Dedkova","year":"2003","journal-title":"Circ. Res."},{"key":"2021113010490533900_B49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2170\/physiolsci.RP002305","article-title":"Nitric oxide stimulates vascular endothelial growth factor production in cardiomyocytes involved in angiogenesis","volume":"56","author":"Kuwabara","year":"2006","journal-title":"J. Physiol. Sci."},{"key":"2021113010490533900_B50","first-page":"623","article-title":"Role of nitric oxide in the control of the gastric motility within the nucleus ambiguus of rats","volume":"63","author":"Sun","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"2021113010490533900_B51","first-page":"159","article-title":"Why is nitric oxide important for our brain?","volume":"30","author":"D\u017eolji\u0107","year":"2015","journal-title":"Funct. Neurol."},{"key":"2021113010490533900_B52","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1152\/physrev.00048.2010","article-title":"Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors","volume":"92","author":"Petho","year":"2012","journal-title":"Physiol. Rev."},{"key":"2021113010490533900_B53","doi-asserted-by":"publisher","first-page":"H234","DOI":"10.1152\/ajpheart.00037.2002","article-title":"Effect of nitric oxide on excitatory amino acid-evoked discharge of neurons in NTS","volume":"284","author":"Dias","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010490533900_B54","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010490533900_B55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10557-012-6424-y","article-title":"RAAS inhibitors and cardiovascular protection in large scale trials","volume":"27","author":"von Lueder","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"2021113010490533900_B56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2119\/molmed.2014.00125","article-title":"Cholinergic activity as a new target in diseases of the heart","volume":"20","author":"Roy","year":"2015","journal-title":"Mol. Med."},{"key":"2021113010490533900_B57","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/eht182","article-title":"The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease","volume":"34","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur. Heart J."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/21\/1913\/448434\/cs1301913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/21\/1913\/448434\/cs1301913.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:37:46Z","timestamp":1638272266000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/130\/21\/1913\/71564\/Non-neuronal-cardiac-cholinergic-system-influences"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":57,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20160277","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}